FindTrial
Sign In

Use of tigecycline in children with infection

Use of tigecycline in children with infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015715
Enrollment
Unknown
Registered
2018-04-16
Start date
2017-10-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infection in children

Interventions

Case series:no

Sponsors

Zhejiang University School of Medicine Children's Hospital, Pediatric Intensive Care Unit
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: patients those receive intravenous tigecycline between 2012/05/01 and 2017/05/01

Exclusion criteria

Exclusion criteria: duration of tigecycline therapy is less than 2 days (4 dose)

Design outcomes

Primary

MeasureTime frame
temperature;CRP;bacteria culture;—

Countries

China

Contacts

Public ContactSheng Ye

Zhejiang University School of Medicine Children's Hospital, Pediatric Intensive Care Unit

yeshengchina@zju.edu.cn+86 13588074637

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026